Global and China Alpha- Antitrypsin Deficiency Treatment Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Alpha- Antitrypsin Deficiency Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Editas Medicine, Inc

    • Ionis Pharmaceuticals, Inc

    • International Stem Cell Corporation

    • Alnylam Pharmaceuticals, Inc

    • Dicerna Pharmaceuticals, Inc

    • Digna Biotech, SL

    • Grifols, SA

    • Polyphor Ltd

    • Sangamo BioSciences, Inc

    • Inhibrx

    • ProMetic Life Sciences Inc

    • Kamada Ltd

    • rEVO Biologics, Inc

    • Carolus Therapeutics, Inc

    • Intellia Therapeutics, Inc

    • Cevec Pharmaceuticals GmbH

    • Adverum Biotechnologies, Inc

    • Arrowhead Pharmaceuticals, Inc

    • Applied Genetic Technologies Corporation

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • CT-2009

    • POL-6014

    • ARO-AAT

    • ALNAAT-02

    • Others

    Application:

    • Clinic

    • Hospital

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Alpha- Antitrypsin Deficiency Treatment Industry Overview

      • 1.1.1 Alpha- Antitrypsin Deficiency Treatment Market Scope and Market Segments

      • 1.1.2 Alpha- Antitrypsin Deficiency Treatment Industry Characteristics

      • 1.1.3 Global and China Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Alpha- Antitrypsin Deficiency Treatment Production Value and Growth Rate (2017-2028)

    • 1.2 Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 CT-2009

      • 1.2.2 POL-6014

      • 1.2.3 ARO-AAT

      • 1.2.4 ALNAAT-02

      • 1.2.5 Others

    • 1.3 Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Clinic

      • 1.3.2 Hospital

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Alpha- Antitrypsin Deficiency Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Alpha- Antitrypsin Deficiency Treatment Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Alpha- Antitrypsin Deficiency Treatment Industry Porter's Five Forces Model Analysis

      • 2.2.3 Alpha- Antitrypsin Deficiency Treatment Industry PEST Analysis

    • 2.3 Alpha- Antitrypsin Deficiency Treatment Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Alpha- Antitrypsin Deficiency Treatment Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Alpha- Antitrypsin Deficiency Treatment Industry

    Chapter 3 Global and China Alpha- Antitrypsin Deficiency Treatment Market, by Manufacturer

    • 3.1 Global and China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Alpha- Antitrypsin Deficiency Treatment Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Alpha- Antitrypsin Deficiency Treatment Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Alpha- Antitrypsin Deficiency Treatment Market Top 3 Players

    Chapter 4 Global and China Alpha- Antitrypsin Deficiency Treatment Market, by Type (2017-2028)

    • 4.1 Alpha- Antitrypsin Deficiency Treatment Market Trend, by Type

    • 4.2 Global Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Alpha- Antitrypsin Deficiency Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Alpha- Antitrypsin Deficiency Treatment Price Trend, by Type (2017-2028)

    • 4.3 China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Alpha- Antitrypsin Deficiency Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Alpha- Antitrypsin Deficiency Treatment Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Alpha- Antitrypsin Deficiency Treatment Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Alpha- Antitrypsin Deficiency Treatment Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Alpha- Antitrypsin Deficiency Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Alpha- Antitrypsin Deficiency Treatment Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Alpha- Antitrypsin Deficiency Treatment Market Analysis

    • 7.1 North America Alpha- Antitrypsin Deficiency Treatment Market, by Type

    • 7.2 North America Alpha- Antitrypsin Deficiency Treatment Market, by Application

    • 7.3 North America Alpha- Antitrypsin Deficiency Treatment Market Analysis and Forecast, by Country

      • 7.3.1 United States Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Alpha- Antitrypsin Deficiency Treatment Market Analysis

    • 8.1 Europe Alpha- Antitrypsin Deficiency Treatment Market, by Type

    • 8.2 Europe Alpha- Antitrypsin Deficiency Treatment Market, by Application

    • 8.3 Europe Alpha- Antitrypsin Deficiency Treatment Market Analysis and Forecast, by Country

      • 8.3.1 Germany Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Alpha- Antitrypsin Deficiency Treatment Market Analysis

    • 9.1 APAC Alpha- Antitrypsin Deficiency Treatment Market, by Type

    • 9.2 APAC Alpha- Antitrypsin Deficiency Treatment Market, by Application

    • 9.3 APAC Alpha- Antitrypsin Deficiency Treatment Market Analysis and Forecast, by Country

      • 9.3.1 China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Market Analysis

    • 10.1 Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Market, by Type

    • 10.2 Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Market, by Application

    • 10.3 Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Alpha- Antitrypsin Deficiency Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Alpha- Antitrypsin Deficiency Treatment Company Profiles

      • 11.1 Editas Medicine, Inc

        • 11.1.1 Editas Medicine, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Editas Medicine, Inc Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.1.3 Editas Medicine, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Ionis Pharmaceuticals, Inc

        • 11.2.1 Ionis Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Ionis Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.2.3 Ionis Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 International Stem Cell Corporation

        • 11.3.1 International Stem Cell Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.3.3 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Alnylam Pharmaceuticals, Inc

        • 11.4.1 Alnylam Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Alnylam Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.4.3 Alnylam Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Dicerna Pharmaceuticals, Inc

        • 11.5.1 Dicerna Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Dicerna Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.5.3 Dicerna Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Digna Biotech, SL

        • 11.6.1 Digna Biotech, SL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Digna Biotech, SL Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.6.3 Digna Biotech, SL Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Grifols, SA

        • 11.7.1 Grifols, SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Grifols, SA Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.7.3 Grifols, SA Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Polyphor Ltd

        • 11.8.1 Polyphor Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Polyphor Ltd Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.8.3 Polyphor Ltd Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Sangamo BioSciences, Inc

        • 11.9.1 Sangamo BioSciences, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Sangamo BioSciences, Inc Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.9.3 Sangamo BioSciences, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Inhibrx

        • 11.10.1 Inhibrx Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Inhibrx Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.10.3 Inhibrx Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 ProMetic Life Sciences Inc

        • 11.11.1 ProMetic Life Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 ProMetic Life Sciences Inc Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.11.3 ProMetic Life Sciences Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Kamada Ltd

        • 11.12.1 Kamada Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Kamada Ltd Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.12.3 Kamada Ltd Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 rEVO Biologics, Inc

        • 11.13.1 rEVO Biologics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 rEVO Biologics, Inc Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.13.3 rEVO Biologics, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Carolus Therapeutics, Inc

        • 11.14.1 Carolus Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Carolus Therapeutics, Inc Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.14.3 Carolus Therapeutics, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Intellia Therapeutics, Inc

        • 11.15.1 Intellia Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Intellia Therapeutics, Inc Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.15.3 Intellia Therapeutics, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Cevec Pharmaceuticals GmbH

        • 11.16.1 Cevec Pharmaceuticals GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.16.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Adverum Biotechnologies, Inc

        • 11.17.1 Adverum Biotechnologies, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Adverum Biotechnologies, Inc Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.17.3 Adverum Biotechnologies, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Arrowhead Pharmaceuticals, Inc

        • 11.18.1 Arrowhead Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Arrowhead Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.18.3 Arrowhead Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Applied Genetic Technologies Corporation

        • 11.19.1 Applied Genetic Technologies Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Product Profiles, Application and Specification

        • 11.19.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Alpha- Antitrypsin Deficiency Treatment Industry Investment Prospect and Risk Assessment

    • 12.1 Alpha- Antitrypsin Deficiency Treatment Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Alpha- Antitrypsin Deficiency Treatment Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Production Value and Growth Rate (2017-2028)

    • Figure China Alpha- Antitrypsin Deficiency Treatment Production Value and Growth Rate (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of CT-2009 (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of POL-6014 (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of ARO-AAT (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of ALNAAT-02 (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Clinic (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Alpha- Antitrypsin Deficiency Treatment Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Alpha- Antitrypsin Deficiency Treatment Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Alpha- Antitrypsin Deficiency Treatment Market Share, by Manufacturer in 2021

    • Figure Global and China Alpha- Antitrypsin Deficiency Treatment Market Share, by Manufacturer in 2022

    • Table Global Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Type (2017-2028)

    • Table Global Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Type (2017-2028)

    • Table Global Alpha- Antitrypsin Deficiency Treatment Sales Value, by Type (2017-2028)

    • Table Global Alpha- Antitrypsin Deficiency Treatment Sales Value Share, by Type (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Price Trend, by Type (2017-2028)

    • Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Type (2017-2028)

    • Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Type (2017-2028)

    • Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Type (2017-2028)

    • Table China Alpha- Antitrypsin Deficiency Treatment Sales Value, by Type (2017-2028)

    • Table China Alpha- Antitrypsin Deficiency Treatment Sales Value Share, by Type (2017-2028)

    • Figure China Alpha- Antitrypsin Deficiency Treatment Price Trend, by Type (2017-2028)

    • Table Global Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Application (2017-2028)

    • Table Global Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Application (2017-2028)

    • Table Global Alpha- Antitrypsin Deficiency Treatment Sales Value, by Application (2017-2028)

    • Table Global Alpha- Antitrypsin Deficiency Treatment Sales Value Share, by Application (2017-2028)

    • Figure Global Alpha- Antitrypsin Deficiency Treatment Sales Value Share, by Application (2017-2028)

    • Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Application (2017-2028)

    • Table China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Application (2017-2028)

    • Table China Alpha- Antitrypsin Deficiency Treatment Sales Value, by Application (2017-2028)

    • Table China Alpha- Antitrypsin Deficiency Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Alpha- Antitrypsin Deficiency Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure North America Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Production, Import, Consumption and Export (2017-2022)

    • Table North America Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Type (2017-2028)

    • Table North America Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Type (2017-2028)

    • Figure North America Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Type (2017-2028)

    • Table North America Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Application (2017-2028)

    • Table North America Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Application (2017-2028)

    • Figure North America Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Application (2017-2028)

    • Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure United States Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Canada Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Table Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Type (2017-2028)

    • Table Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Type (2017-2028)

    • Table Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Application (2017-2028)

    • Table Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Europe Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Germany Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure UK Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure UK Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure France Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure France Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Italy Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Spain Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Poland Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Russia Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Table APAC Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Type (2017-2028)

    • Table APAC Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Type (2017-2028)

    • Figure APAC Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Type (2017-2028)

    • Table APAC Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Application (2017-2028)

    • Table APAC Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Application (2017-2028)

    • Figure APAC Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure India Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure India Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Alpha- Antitrypsin Deficiency Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Alpha- Antitrypsin Deficiency Treatment Sales Value and Growth Rate (2017-2028)

    • Table Editas Medicine, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Editas Medicine, Inc Product Profiles, Application and Specification

    • Table Editas Medicine, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ionis Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ionis Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Ionis Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table International Stem Cell Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table International Stem Cell Corporation Product Profiles, Application and Specification

    • Table International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alnylam Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alnylam Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Alnylam Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dicerna Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dicerna Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Dicerna Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Digna Biotech, SL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Digna Biotech, SL Product Profiles, Application and Specification

    • Table Digna Biotech, SL Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Grifols, SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Grifols, SA Product Profiles, Application and Specification

    • Table Grifols, SA Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Polyphor Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Polyphor Ltd Product Profiles, Application and Specification

    • Table Polyphor Ltd Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sangamo BioSciences, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sangamo BioSciences, Inc Product Profiles, Application and Specification

    • Table Sangamo BioSciences, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Inhibrx Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Inhibrx Product Profiles, Application and Specification

    • Table Inhibrx Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ProMetic Life Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ProMetic Life Sciences Inc Product Profiles, Application and Specification

    • Table ProMetic Life Sciences Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kamada Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kamada Ltd Product Profiles, Application and Specification

    • Table Kamada Ltd Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table rEVO Biologics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table rEVO Biologics, Inc Product Profiles, Application and Specification

    • Table rEVO Biologics, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Carolus Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Carolus Therapeutics, Inc Product Profiles, Application and Specification

    • Table Carolus Therapeutics, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Intellia Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Intellia Therapeutics, Inc Product Profiles, Application and Specification

    • Table Intellia Therapeutics, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cevec Pharmaceuticals GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cevec Pharmaceuticals GmbH Product Profiles, Application and Specification

    • Table Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Adverum Biotechnologies, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Adverum Biotechnologies, Inc Product Profiles, Application and Specification

    • Table Adverum Biotechnologies, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Arrowhead Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Arrowhead Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Arrowhead Pharmaceuticals, Inc Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Applied Genetic Technologies Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Applied Genetic Technologies Corporation Product Profiles, Application and Specification

    • Table Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.